Intensity Therapeutics, Inc. , a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors.
Intensity Therapeutics stock last closed at $0.32, down 0.63% from the previous day, and has decreased 93.35% in one year. It has underperformed other stocks in the Biotechnology industry by 0.17 percentage points. Intensity Therapeutics stock is currently +11.97% from its 52-week low of $0.28, and -93.76% from its 52-week high of $5.10.
At the moment, there are 18.4M INTS shares outstanding. The market value of INTS is $5.85M. In the last 24 hours, 2.17M INTS shares were traded.
You will need a brokerage account to access the NASDAQ market and buy INTS stock.
In our opinion, eToro is the best brokerage. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, the next step is to fill out some personal information so you can buy INTS stock today.
Now that you've created your account on app for stock, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help depositing funds into your brokerage account.
After you have figured out the best place to buy Intensity Therapeutics stock, it's very important to evaluate their stock before you buy, so you truly understand the risk as well as the upside.
WallStreetZen was designed to help everyday investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on INTS's stock page.
You can use many financial metrics, analyses, models, and charts to gauge INTS's true value.
Using relative valuations metrics:
You can do more valuation research on INTS's stock here.
Out of 1 sell side analysts who track INTS, the consensus analyst rating on INTS is a Strong Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Intensity Therapeutics stock forecast page.
Over the last 12 months, insiders at INTS have not bought or sold any shares.
Research more about who owns INTS stock here.
No, Intensity Therapeutics doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
There are two primary options:
Hit the Open Trade button and your broker will execute the order.
If you need additional assistance investing in stocks on eToro, click the helpful video below:
Now that you own some INTS shares, you'll want to keep up with your new investment.
Make a watchlist to get notified of the latest news about your INTS stock.
To reiterate, here are the 6 steps to buy stock in Intensity Therapeutics:
If you are looking for a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Intensity Therapeutics, hit the button below to create your watchlist.